SKBI [SKYSTAR BIO-PHARMACEUTICAL] S-3: FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT
[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933ystar Bio-Pharmaceuticalmpany Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer oforporation or organization)de Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xian, Shaanxi Province, P.R. China (8629) 8819-3188] [SKYSTAR BIO-PHARMACEUTICALMPANY TO TRUSTEE INDENTURETED OF , 20 SENIOR DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 8 SECTION1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8 SECTION1.4 ACTS OF HOLDERS; RECORDTES] [SKYSTAR BIO-PHARMACEUTICALMPANY TO TRUSTEE INDENTURETED OF , 20 SUBORDINATED DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10 SECTION 1.4 ACTS OF HOLDERS; RECORDTES] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in the Registration Statement on Form S-3 and related Prospectus of our reportted April 1, 2013 relating to thensolidated financial statements, which appears inystar Bio-Pharmaceuticalmpanys Annual Report on Form 10-K for the year ended December 31, 2012.] [Consent of Independent Registered Public Accounting Firm Wensent to theorporation by reference in this Registration Statement on Form S-3 and related Prospectus ofystar Bio-Pharmaceuticalmpany of our reportted March 30, 2012 relating to the December 31, 2011nsolidated financial statements appearing in the Annual Report on Form 10-K ofystar Bio-Pharmaceuticalmpany for the year ended December 31, 2012,]